Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 35.37 USD -4.22% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Verona Pharma PLC
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Verona Pharma PLC
Depreciation & Amortization Peer Comparison

Comparables:
GSK
AZN
INDV
HIK
DPH

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Verona Pharma PLC
NASDAQ:VRNA
Depreciation & Amortization
$1m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
GlaxoSmithKline PLC
LSE:GSK
Depreciation & Amortization
ÂŁ2.9B
CAGR 3-Years
-3%
CAGR 5-Years
-1%
CAGR 10-Years
18%
AstraZeneca PLC
LSE:AZN
Depreciation & Amortization
$5.1B
CAGR 3-Years
18%
CAGR 5-Years
6%
CAGR 10-Years
2%
Indivior PLC
LSE:INDV
Depreciation & Amortization
$50m
CAGR 3-Years
28%
CAGR 5-Years
2%
CAGR 10-Years
6%
Hikma Pharmaceuticals PLC
LSE:HIK
Depreciation & Amortization
$219m
CAGR 3-Years
31%
CAGR 5-Years
15%
CAGR 10-Years
12%
Dechra Pharmaceuticals PLC
LSE:DPH
Depreciation & Amortization
ÂŁ89.7m
CAGR 3-Years
85%
CAGR 5-Years
65%
CAGR 10-Years
15%

See Also

What is Verona Pharma PLC's Depreciation & Amortization?
Depreciation & Amortization
1m USD

Based on the financial report for Sep 30, 2024, Verona Pharma PLC's Depreciation & Amortization amounts to 1m USD.

What is Verona Pharma PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
26%

Over the last year, the Depreciation & Amortization growth was 63%. The average annual Depreciation & Amortization growth rates for Verona Pharma PLC have been 26% over the past three years .

Back to Top